Efficacy And Safety Of Nabiximols (Sativex(®)) On Multiple Sclerosis Spasticity In A Real-life Italian Monocentric Study

Multiple Sclerosis (MS)

Key Findings

This real-world study confirms nabiximols efficacy and safety in the treatment of MS-related spasticity and pain, which is maintained up to 48 weeks.

Information and Links


Link: Efficacy And Safety Of Nabiximols (Sativex(®)) On Multiple Sclerosis Spasticity In A Real-life Italian Monocentric Study

Year: 2016

DOI: 10.1007/s10072-015-2392-x


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 3


Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

Sativex (THC:CBD)